| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |